PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...
IBC is a rare, aggressive breast cancer with higher rates in younger women and those of African descent, requiring a ...
SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Abhi Moolupuri discussing a PET/CT supplemented approach to omission of pelvic lymph node dissection. The National ...
One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...
Avita Health System’s renovations on a $15 million, 22,000-square-foot comprehensive cancer center at Avita South Campus are ...
(UroToday.com) Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics 2025 held in Lugano, Switzerland was host to a session addressing the contemporary management of metastatic prostate ...
Srinagar- The government on Friday said that Jammu and Kashmir reports 2 to 3 percent increase in cancer cases every year.
Award-winning research presented at ESR 2025 reveals energy-efficient diagnostic approaches for metastatic breast cancer, ...
Pluvicto is a new radiopharmaceutical treatment for advanced prostate cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results